首页 > 最新文献

Population Health Management最新文献

英文 中文
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy. 鉴定心衰患者是否有资格接受指导药物治疗。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1089/pop.2024.0132
Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, Sanjay Kumar, David Zelle, John W Ostrominski, Hunter Nichols, Jacqueline Chasse, Marian McPartlin, Megan Twining, Emma Collins, Echo Fridley, Christian Figueroa, Ryan Ruggiero, Matthew Varugheese, Michael Oates, Christopher P Cannon, Akshay S Desai, Samuel Aronson, Alexander J Blood, Benjamin Scirica, Kavishwar B Wagholikar

A majority of patients with heart failure (HF) do not receive adequate medical therapy as recommended by clinical guidelines. One major obstacle encountered by population health management (PHM) programs to improve medication usage is the substantial burden placed on clinical staff who must manually sift through electronic health records (EHRs) to ascertain patients' eligibility for the guidelines. As a potential solution, the study team developed a rule-based system (RBS) that automatically parses the EHR for identifying patients with HF who may be eligible for guideline-directed therapy. The RBS was deployed to streamline a PHM program at Brigham and Women's Hospital wherein the RBS was executed every other month to identify potentially eligible patients for further screening by the program staff. The study team evaluated the performance of the system and performed an error analysis to identify areas for improving the system. Of approximately 161,000 patients who have an echocardiogram in the health system, each execution of the RBS typically identified around 4200 patients. A total 5460 patients were manually screened, of which 1754 were found to be truly eligible with an accuracy of 32.1%. An analysis of the false-positive cases showed that over 38% of the false positives were due to incorrect determination of symptomatic HF and medication history of the patients. The system's performance can be potentially improved by integrating information from clinical notes. The RBS provided a systematic way to narrow down the patient population to a subset that is enriched for eligible patients. However, there is a need to further optimize the system by integrating processing of clinical notes. This study highlights the practical challenges of implementing automated tools to facilitate guideline-directed care.

大多数心力衰竭(HF)患者没有按照临床指南的建议接受足够的药物治疗。人口健康管理(PHM)项目在改善药物使用方面遇到的一个主要障碍是,临床工作人员必须手动筛选电子健康记录(EHRs),以确定患者是否符合指南的要求,这给他们带来了沉重的负担。作为一种潜在的解决方案,研究小组开发了一种基于规则的系统(RBS),该系统可以自动解析EHR,以识别可能有资格接受指导治疗的心衰患者。在布里格姆妇女医院(Brigham and Women's Hospital),每隔一个月执行一次RBS,以确定潜在的合格患者,由项目工作人员进行进一步筛查。研究小组评估了系统的性能,并进行了错误分析,以确定需要改进系统的地方。在医疗系统中接受超声心动图检查的约16.1万名患者中,每次执行RBS通常会识别出约4200名患者。人工筛选5460例患者,其中1754例发现真正符合条件,准确率为32.1%。对假阳性病例的分析表明,超过38%的假阳性是由于对症状性心衰和患者用药史的判断错误造成的。通过整合来自临床记录的信息,系统的性能可以得到潜在的改善。RBS提供了一种系统的方法,将患者人群缩小到一个子集,丰富了符合条件的患者。然而,还需要通过整合临床记录的处理来进一步优化系统。本研究强调了实施自动化工具以促进指导护理的实际挑战。
{"title":"Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy.","authors":"Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, Sanjay Kumar, David Zelle, John W Ostrominski, Hunter Nichols, Jacqueline Chasse, Marian McPartlin, Megan Twining, Emma Collins, Echo Fridley, Christian Figueroa, Ryan Ruggiero, Matthew Varugheese, Michael Oates, Christopher P Cannon, Akshay S Desai, Samuel Aronson, Alexander J Blood, Benjamin Scirica, Kavishwar B Wagholikar","doi":"10.1089/pop.2024.0132","DOIUrl":"10.1089/pop.2024.0132","url":null,"abstract":"<p><p>A majority of patients with heart failure (HF) do not receive adequate medical therapy as recommended by clinical guidelines. One major obstacle encountered by population health management (PHM) programs to improve medication usage is the substantial burden placed on clinical staff who must manually sift through electronic health records (EHRs) to ascertain patients' eligibility for the guidelines. As a potential solution, the study team developed a rule-based system (RBS) that automatically parses the EHR for identifying patients with HF who may be eligible for guideline-directed therapy. The RBS was deployed to streamline a PHM program at Brigham and Women's Hospital wherein the RBS was executed every other month to identify potentially eligible patients for further screening by the program staff. The study team evaluated the performance of the system and performed an error analysis to identify areas for improving the system. Of approximately 161,000 patients who have an echocardiogram in the health system, each execution of the RBS typically identified around 4200 patients. A total 5460 patients were manually screened, of which 1754 were found to be truly eligible with an accuracy of 32.1%. An analysis of the false-positive cases showed that over 38% of the false positives were due to incorrect determination of symptomatic HF and medication history of the patients. The system's performance can be potentially improved by integrating information from clinical notes. The RBS provided a systematic way to narrow down the patient population to a subset that is enriched for eligible patients. However, there is a need to further optimize the system by integrating processing of clinical notes. This study highlights the practical challenges of implementing automated tools to facilitate guideline-directed care.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"374-381"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In the "Drivers'" Seat: How to Improve Drivers of Health, from Vision to Impact. 坐在 "驾驶员 "的位置上:如何改善健康的驱动因素,从愿景到影响。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-12-01 Epub Date: 2024-11-19 DOI: 10.1089/pop.2024.0148
Ann Somers Hogg, Alexandra Schweitzer

Despite focusing on drivers of health, or social determinants of health, for more than a decade, health care organizations have made minimal progress in improving these factors and associated health outcomes. This data- and theory-driven analysis looks at (1) why that is the case and (2) how organizational leaders and operators can go about correcting it. The authors' research finds that lack of progress is often due to ill-fit, entrenched business models that were optimized for a fee-for-service environment and cannot easily pivot to focus on drivers of health. Additionally, leaders are often unclear about what to change and overwhelmed by how to do it. The authors propose a 5-step strategy and execution process to address these challenges, laying out an end-to-end road map that enables health care leaders to meaningfully improve drivers of health and associated health outcomes for their patients and communities.

尽管十多年来一直关注健康的驱动因素或健康的社会决定因素,但医疗机构在改善这些因素和相关健康结果方面取得的进展微乎其微。这篇以数据和理论为导向的分析报告探讨了:(1)为什么会出现这种情况;(2)组织领导者和运营者如何纠正这种情况。作者的研究发现,缺乏进展往往是由于业务模式不合适、根深蒂固,这些模式针对收费服务环境进行了优化,不能轻易转向关注健康驱动因素。此外,领导者往往不清楚要改变什么,也不知如何改变。作者提出了应对这些挑战的五步战略和执行流程,列出了端到端的路线图,使医疗保健领导者能够切实改善健康驱动因素,并为患者和社区带来相关的健康成果。
{"title":"In the \"Drivers'\" Seat: How to Improve Drivers of Health, from Vision to Impact.","authors":"Ann Somers Hogg, Alexandra Schweitzer","doi":"10.1089/pop.2024.0148","DOIUrl":"10.1089/pop.2024.0148","url":null,"abstract":"<p><p>Despite focusing on drivers of health, or social determinants of health, for more than a decade, health care organizations have made minimal progress in improving these factors and associated health outcomes. This data- and theory-driven analysis looks at (1) why that is the case and (2) how organizational leaders and operators can go about correcting it. The authors' research finds that lack of progress is often due to ill-fit, entrenched business models that were optimized for a fee-for-service environment and cannot easily pivot to focus on drivers of health. Additionally, leaders are often unclear about what to change and overwhelmed by how to do it. The authors propose a 5-step strategy and execution process to address these challenges, laying out an end-to-end road map that enables health care leaders to meaningfully improve drivers of health and associated health outcomes for their patients and communities.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"408-414"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Social Risk ACTIONS Framework: Characterizing Responses to Social Risks by Health Care Delivery Organizations. 社会风险行动框架:社会风险行动框架:描述医疗服务机构应对社会风险的措施。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-12-01 Epub Date: 2024-11-25 DOI: 10.1089/pop.2024.0162
Mayuree Rao, Matthew L Maciejewski, Karin Nelson, Alicia J Cohen, Hill L Wolfe, Leah Marcotte, Donna M Zulman

Social risks refer to individuals' social and economic conditions shaped by underlying social determinants of health. Health care delivery organizations increasingly screen patients for social risks given their potential impact on health outcomes. However, it can be challenging to meaningfully address patients' needs. Existing frameworks do not comprehensively describe and classify ways in which health care delivery organizations can address social risks after screening. Addressing this gap, the authors developed the Social Risk ACTIONS framework (Actionability Characteristics To Inform Organizations' Next steps after Screening) describing 4 dimensions of actionability: Level of action, Actor, Purpose of action, and Action. First, social risk actions can occur at 3 organizational levels (ie, patient encounter, clinical practice/institution, community). Second, social risk actions are initiated by different staff members, referred to as "actors" (ie, clinical care professionals with direct patient contact, clinical/institutional leaders, and researchers). Third, social risk actions can serve one or more purposes: strengthening relationships with patients, tailoring care, modifying the social risk itself, or facilitating population health, research, or advocacy. Finally, specific actions on social risks vary by level, actor, and purpose. This article presents the Social Risk ACTIONS framework, applies its concepts to 2 social risks (food insecurity and homelessness), and discusses its broader applications and implications. The framework offers an approach for leaders of health care delivery organizations to assess current efforts and identify additional opportunities to address social risks. Future work should validate this framework with patients, clinicians, and health care leaders, and incorporate implementation challenges to social risk action.

社会风险指的是个人的社会和经济状况,由潜在的健康社会决定因素所决定。鉴于社会风险对健康结果的潜在影响,医疗服务机构越来越多地对患者进行社会风险筛查。然而,要有意义地满足患者的需求可能具有挑战性。现有的框架并没有对医疗服务机构在筛查后应对社会风险的方式进行全面的描述和分类。针对这一空白,作者开发了社会风险 ACTIONS 框架(筛查后告知组织下一步行动的可操作性特征),描述了可操作性的 4 个维度:行动级别、行动者、行动目的和行动。首先,社会风险行动可发生在 3 个组织层面(即患者就诊、临床实践/机构、社区)。第二,社会风险行动由不同的工作人员发起,这些工作人员被称为 "行动者"(即直接接触患者的临床护理专业人员、临床/机构领导和研究人员)。第三,社会风险行动可以达到一个或多个目的:加强与患者的关系,量身定制护理,改变社会风险本身,或促进人口健康、研究或宣传。最后,针对社会风险的具体行动因级别、参与者和目的而异。本文介绍了社会风险行动框架,将其概念应用于两种社会风险(粮食不安全和无家可归),并讨论了其更广泛的应用和影响。该框架为医疗保健服务机构的领导者提供了一种评估当前工作的方法,并确定了应对社会风险的更多机会。未来的工作应与患者、临床医生和医疗保健领导者一起验证该框架,并将实施社会风险行动所面临的挑战纳入其中。
{"title":"The Social Risk ACTIONS Framework: Characterizing Responses to Social Risks by Health Care Delivery Organizations.","authors":"Mayuree Rao, Matthew L Maciejewski, Karin Nelson, Alicia J Cohen, Hill L Wolfe, Leah Marcotte, Donna M Zulman","doi":"10.1089/pop.2024.0162","DOIUrl":"10.1089/pop.2024.0162","url":null,"abstract":"<p><p>Social risks refer to individuals' social and economic conditions shaped by underlying social determinants of health. Health care delivery organizations increasingly screen patients for social risks given their potential impact on health outcomes. However, it can be challenging to meaningfully address patients' needs. Existing frameworks do not comprehensively describe and classify ways in which health care delivery organizations can address social risks after screening. Addressing this gap, the authors developed the Social Risk ACTIONS framework (Actionability Characteristics To Inform Organizations' Next steps after Screening) describing 4 dimensions of actionability: Level of action, Actor, Purpose of action, and Action. First, social risk actions can occur at 3 organizational levels (ie, patient encounter, clinical practice/institution, community). Second, social risk actions are initiated by different staff members, referred to as \"actors\" (ie, clinical care professionals with direct patient contact, clinical/institutional leaders, and researchers). Third, social risk actions can serve one or more purposes: strengthening relationships with patients, tailoring care, modifying the social risk itself, or facilitating population health, research, or advocacy. Finally, specific actions on social risks vary by level, actor, and purpose. This article presents the Social Risk ACTIONS framework, applies its concepts to 2 social risks (food insecurity and homelessness), and discusses its broader applications and implications. The framework offers an approach for leaders of health care delivery organizations to assess current efforts and identify additional opportunities to address social risks. Future work should validate this framework with patients, clinicians, and health care leaders, and incorporate implementation challenges to social risk action.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"397-404"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and Framework of a Technology-Based Closed-Loop Referral Project for Care Coordination of Social Determinants of Health. 基于技术的闭环转诊项目的设计和框架,以协调健康的社会决定因素。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-12-01 Epub Date: 2024-11-28 DOI: 10.1089/pop.2024.0129
Shreela V Sharma, Heidi McPherson, Micaela Sandoval, David Goodman, Carol Paret, Kallol Mahata, Junaid Husain, James Gallagher, Eric Boerwinkle

Screening for social determinants of health (SDOH) has been mandated by health systems nationwide. However, a gap exists in closed-loop referral for care coordination between health care and social services. This article presents the framework of a technology-based project to facilitate closed-loop referral between health care and social service agencies in Greater Houston by leveraging and connecting the existing care coordination technology infrastructure. Ten health care and social service organizations in Greater Houston participated in the demonstration project initiated in January 2023. The authors leveraged and linked regional health information exchange (HIE) technology with a master patient index of >18 million, and sector-specific care coordination platforms to build closed-loop referral capacity between HIE-participating health care organizations and social service organizations to meet patient SDOH needs. Evaluation efforts will assess the reach, adoption, implementation, and the effectiveness of the closed-loop framework in improving social and health outcomes. The framework comprised the following 4 components: (1) establishment of collaborative governance for shared decision-making processes, fostering trust, alignment, and transparency among organizations; (2) development of technology linkages between existing platforms to facilitate seamless referrals between organizations and ensure visibility of referral outcomes; (3) integration of regional resource directories into technology infrastructure to ensure resource accessibility/quality; and (4) evaluation of the system's impact on health equity, efficiency, and cost reduction. This project aimed to close the loop for care coordination between health care and social service agencies, enable data evaluation to determine care coordination effectiveness, and lay the foundation for SDOH-related research/practice equitably.

全国的医疗系统都已强制要求对健康的社会决定因素(SDOH)进行筛查。然而,在医疗保健与社会服务之间的闭环转介护理协调方面还存在差距。本文介绍了一个基于技术的项目框架,通过利用和连接现有的护理协调技术基础设施,促进大休斯顿地区医疗保健和社会服务机构之间的闭环转介。大休斯顿地区的十家医疗和社会服务机构参与了 2023 年 1 月启动的示范项目。作者利用并连接了拥有超过 1800 万患者主索引的区域医疗信息交换 (HIE) 技术和特定部门的护理协调平台,在参与 HIE 的医疗机构和社会服务机构之间建立闭环转诊能力,以满足患者的 SDOH 需求。评估工作将对闭环框架的覆盖范围、采用、实施以及在改善社会和健康成果方面的有效性进行评估。该框架由以下 4 个部分组成:(1)建立共同决策过程的合作治理,促进组织间的信任、协调和透明;(2)开发现有平台间的技术链接,促进组织间的无缝转诊,确保转诊结果的可见性;(3)将区域资源目录整合到技术基础设施中,确保资源的可获得性/质量;以及(4)评估系统对健康公平、效率和成本降低的影响。该项目旨在为医疗保健和社会服务机构之间的护理协调提供闭环,使数据评估能够确定护理协调的有效性,并为与 SDOH 相关的研究/公平实践奠定基础。
{"title":"Design and Framework of a Technology-Based Closed-Loop Referral Project for Care Coordination of Social Determinants of Health.","authors":"Shreela V Sharma, Heidi McPherson, Micaela Sandoval, David Goodman, Carol Paret, Kallol Mahata, Junaid Husain, James Gallagher, Eric Boerwinkle","doi":"10.1089/pop.2024.0129","DOIUrl":"10.1089/pop.2024.0129","url":null,"abstract":"<p><p>Screening for social determinants of health (SDOH) has been mandated by health systems nationwide. However, a gap exists in closed-loop referral for care coordination between health care and social services. This article presents the framework of a technology-based project to facilitate closed-loop referral between health care and social service agencies in Greater Houston by leveraging and connecting the existing care coordination technology infrastructure. Ten health care and social service organizations in Greater Houston participated in the demonstration project initiated in January 2023. The authors leveraged and linked regional health information exchange (HIE) technology with a master patient index of >18 million, and sector-specific care coordination platforms to build closed-loop referral capacity between HIE-participating health care organizations and social service organizations to meet patient SDOH needs. Evaluation efforts will assess the reach, adoption, implementation, and the effectiveness of the closed-loop framework in improving social and health outcomes. The framework comprised the following 4 components: (1) establishment of collaborative governance for shared decision-making processes, fostering trust, alignment, and transparency among organizations; (2) development of technology linkages between existing platforms to facilitate seamless referrals between organizations and ensure visibility of referral outcomes; (3) integration of regional resource directories into technology infrastructure to ensure resource accessibility/quality; and (4) evaluation of the system's impact on health equity, efficiency, and cost reduction. This project aimed to close the loop for care coordination between health care and social service agencies, enable data evaluation to determine care coordination effectiveness, and lay the foundation for SDOH-related research/practice equitably.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"390-396"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Population Health Management. 罗莎琳德-富兰克林学会自豪地宣布 2023 年人口健康管理奖得主。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 DOI: 10.1089/pop.2024.12337.rfs2023
Marik Moen
{"title":"Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for <i>Population Health Management</i>.","authors":"Marik Moen","doi":"10.1089/pop.2024.12337.rfs2023","DOIUrl":"https://doi.org/10.1089/pop.2024.12337.rfs2023","url":null,"abstract":"","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":"27 5","pages":"299"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profiling Social Needs Activities in Publicly Traded Medicare Advantage Organizations. 剖析公开交易的医疗保险优势组织的社会需求活动。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-27 DOI: 10.1089/pop.2024.0045
Khyathi Gadag, Fred Ullrich, Keith J Mueller

The objective was to examine Medical Advantage (MA) organizations' commitment toward addressing social determinants of health (SDOH) through their health-related social benefit offerings, and the perceived impact of providing supplemental benefits associated with SDOH in their plans. Public reporting documents were reviewed from six of the largest MA firms: Humana, UnitedHealthcare, Cigna, Elevance Health, CVS Health, and Centene. Public reports were obtained from each company's website (eg, from the "Investor Relations" page). Quarterly reports for Q1 2023, annual reports for 2022, and proxy statements for 2023 for all companies were examined. Content analysis of the public reports was conducted under three constructs: (1) Growth of MA in the company, (2) SDOH-related activities in the company, and (3) SDOH-related activities in the MA plans of the company. Each of the three constructs was further analyzed for recurring themes and elements. The findings from content analysis suggests that plans are providing tailored benefits that may address the social needs of vulnerable and underserved populations. Companies that offered supplemental benefits and value-based arrangements that addressed social needs reported beneficiary clinical outcomes resulting in cost savings and increased revenue. Health insurance companies identify MA as a significant growth opportunity and a strategically important market for overall membership and revenue growth. Moreover, companies providing innovative social benefits through their MA plans reported witnessing increased value propositions by underserved and vulnerable populations, leading to increased revenue and cost containment.

目的是研究医疗优势(MA)组织通过提供与健康相关的社会福利来解决健康的社会决定因素(SDOH)的承诺,以及在其计划中提供与 SDOH 相关的补充福利的预期影响。我们审查了六家最大的医疗保险公司的公开报告文件:Humana、UnitedHealthcare、Cigna、Elevance Health、CVS Health 和 Centene。公开报告来自各公司的网站(如 "投资者关系 "页面)。对所有公司 2023 年第一季度的季度报告、2022 年的年度报告和 2023 年的代理声明进行了检查。公开报告的内容分析在三个结构下进行:(1)公司中医疗保险的增长,(2)公司中与 SDOH 相关的活动,(3)公司医疗保险计划中与 SDOH 相关的活动。对这三个结构中的每一个结构都进一步分析了重复出现的主题和要素。内容分析结果表明,医疗保险计划正在提供量身定制的福利,以满足弱势和服务不足人群的社会需求。提供满足社会需求的补充福利和基于价值的安排的公司报告了受益人的临床结果,从而节省了成本并增加了收入。医疗保险公司认为,医疗保险是一个重要的增长机会,也是一个对整体会员和收入增长具有重要战略意义的市场。此外,通过医疗保险计划提供创新性社会福利的公司报告称,服务不足和弱势群体的价值主张得到了提高,从而增加了收入并控制了成本。
{"title":"Profiling Social Needs Activities in Publicly Traded Medicare Advantage Organizations.","authors":"Khyathi Gadag, Fred Ullrich, Keith J Mueller","doi":"10.1089/pop.2024.0045","DOIUrl":"https://doi.org/10.1089/pop.2024.0045","url":null,"abstract":"<p><p>The objective was to examine Medical Advantage (MA) organizations' commitment toward addressing social determinants of health (SDOH) through their health-related social benefit offerings, and the perceived impact of providing supplemental benefits associated with SDOH in their plans. Public reporting documents were reviewed from six of the largest MA firms: Humana, UnitedHealthcare, Cigna, Elevance Health, CVS Health, and Centene. Public reports were obtained from each company's website (eg, from the \"Investor Relations\" page). Quarterly reports for Q1 2023, annual reports for 2022, and proxy statements for 2023 for all companies were examined. Content analysis of the public reports was conducted under three constructs: (1) Growth of MA in the company, (2) SDOH-related activities in the company, and (3) SDOH-related activities in the MA plans of the company. Each of the three constructs was further analyzed for recurring themes and elements. The findings from content analysis suggests that plans are providing tailored benefits that may address the social needs of vulnerable and underserved populations. Companies that offered supplemental benefits and value-based arrangements that addressed social needs reported beneficiary clinical outcomes resulting in cost savings and increased revenue. Health insurance companies identify MA as a significant growth opportunity and a strategically important market for overall membership and revenue growth. Moreover, companies providing innovative social benefits through their MA plans reported witnessing increased value propositions by underserved and vulnerable populations, leading to increased revenue and cost containment.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Timely Outpatient Follow-Up and Readmission Risk in a Mobile Integrated Health Program. 移动综合医疗项目中门诊病人及时随访与再入院风险的关系。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-01 Epub Date: 2024-04-29 DOI: 10.1089/pop.2024.0020
Nicholas Brady, Yuanyuan Liang, Kristin L Seidl, David Marcozzi, Benoit Stryckman, Daniel B Gingold

The objective was to identify medical conditions associated with 30-day readmission, determine patient characteristics for which outpatient follow-up is most associated with reduced readmission, and evaluate how readmission risk changes with time to outpatient follow-up within a mobile integrated health-community paramedicine (MIH-CP) program. This retrospective observational study used data from 1,118 adult patient enrollments in a MIH-CP program operating in Baltimore, Maryland, from May 14, 2018, to December 21, 2021. Bivariate analysis identified chronic disease exacerbations associated with higher 30-day readmission risk. Kaplan-Meier curves and Cox proportional hazard regressions were used to measure how hazard of readmission changes with outpatient follow-up and how that association may vary with other factors. Receiver operating characteristic analysis was used to evaluate how well time to follow-up could predict 30-day readmission. Timely outpatient follow-up was associated with a significant reduction in hazard of readmission for patients aged 50 and younger and for patients with fewer than 5 social determinants of health needs identified. No significant association between readmission and specific chronic disease exacerbations was observed. An optimal follow-up time frame to reduce readmissions could not be identified. Timely outpatient follow-up may be effective for reducing readmissions in younger patients and patients who are less socially complex. Programs and policies aiming to reduce 30-day readmissions may have more success by expanding efforts to include these patients.

目的是确定与 30 天再入院相关的医疗条件,确定门诊随访与减少再入院最相关的患者特征,并评估在移动综合医疗-社区辅助医疗(MIH-CP)项目中,再入院风险如何随门诊随访时间的变化而变化。这项回顾性观察研究使用了 2018 年 5 月 14 日至 2021 年 12 月 21 日在马里兰州巴尔的摩市开展的一项 MIH-CP 计划的 1118 名成年患者注册数据。双变量分析确定了与较高的 30 天再入院风险相关的慢性疾病加重。Kaplan-Meier 曲线和 Cox 比例危险度回归用于测量再入院风险随门诊随访的变化情况,以及这种关联可能随其他因素的变化而变化。接受者操作特征分析用于评估随访时间对 30 天再入院的预测能力。对于年龄在 50 岁及以下的患者和确定了少于 5 项健康社会决定因素需求的患者来说,及时的门诊随访与再入院风险的显著降低有关。未观察到再入院与特定慢性疾病加重之间存在明显关联。无法确定减少再入院的最佳随访时间。及时的门诊随访可能会有效减少年轻患者和社会复杂性较低的患者的再入院率。旨在减少 30 天再入院率的计划和政策若能将这些患者纳入其中,可能会取得更大的成功。
{"title":"Association of Timely Outpatient Follow-Up and Readmission Risk in a Mobile Integrated Health Program.","authors":"Nicholas Brady, Yuanyuan Liang, Kristin L Seidl, David Marcozzi, Benoit Stryckman, Daniel B Gingold","doi":"10.1089/pop.2024.0020","DOIUrl":"10.1089/pop.2024.0020","url":null,"abstract":"<p><p>The objective was to identify medical conditions associated with 30-day readmission, determine patient characteristics for which outpatient follow-up is most associated with reduced readmission, and evaluate how readmission risk changes with time to outpatient follow-up within a mobile integrated health-community paramedicine (MIH-CP) program. This retrospective observational study used data from 1,118 adult patient enrollments in a MIH-CP program operating in Baltimore, Maryland, from May 14, 2018, to December 21, 2021. Bivariate analysis identified chronic disease exacerbations associated with higher 30-day readmission risk. Kaplan-Meier curves and Cox proportional hazard regressions were used to measure how hazard of readmission changes with outpatient follow-up and how that association may vary with other factors. Receiver operating characteristic analysis was used to evaluate how well time to follow-up could predict 30-day readmission. Timely outpatient follow-up was associated with a significant reduction in hazard of readmission for patients aged 50 and younger and for patients with fewer than 5 social determinants of health needs identified. No significant association between readmission and specific chronic disease exacerbations was observed. An optimal follow-up time frame to reduce readmissions could not be identified. Timely outpatient follow-up may be effective for reducing readmissions in younger patients and patients who are less socially complex. Programs and policies aiming to reduce 30-day readmissions may have more success by expanding efforts to include these patients.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"249-256"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term HIV Pre-Exposure Prophylaxis Persistence and Reinitiation in Connecticut from 2012 to 2018. 2012 年至 2018 年康涅狄格州艾滋病毒暴露前预防的长期持续性和重新启动。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-01 Epub Date: 2024-07-09 DOI: 10.1089/pop.2024.0012
Jun Tao, Mofan Gu, Omar Galarraga, Jhanavi Kapadia, Harrison Martin, Hannah Parent, Philip A Chan

HIV pre-exposure prophylaxis (PrEP) is a highly effective biomedical prevention for HIV infections. PrEP persistence is critical to achieving optimal protection against HIV infection. However, little is known about PrEP persistence in the United States. This study utilized the Connecticut All-Payer Claims Database (APCD) to identify PrEP persistence among patients who filled their PrEP prescriptions in the state. The authors identified 1,576 PrEP patients who picked up PrEP prescriptions and extracted medical and pharmacy claims to evaluate a longitudinal cohort during 2012-2018 based on the Connecticut APCD. Patients who did not pick up medication for one consecutive month (ie, 30 days) were defined as discontinuing PrEP. Kaplan-Meier Survival Curve and proportional hazard regression were used to describe PrEP persistence. Of the 1,576 patients who picked up PrEP prescriptions, the median age was 32.0 (interquartile range [IQR]: 22.0-44.0). The majority were male individuals (93%). Of 1,040 patients who discontinued PrEP, 702 (67.5%) restarted PrEP at least once. The median time of PrEP persistence was 3 months (IQR: 1-6 months) for initial PrEP use. The median time on PrEP was also around 3 months in the following episodes of PrEP use. Being female, being on parent's insurance, and having high co-pays were associated with shorter periods of PrEP persistence. PrEP persistence was low among patients who picked up PrEP prescriptions. Although many patients restarted PrEP, persistence remained low during follow-up PrEP use and possibly led to periods of increased HIV risk. Effective interventions are needed to improve PrEP persistence and reduce HIV incidence.

艾滋病毒暴露前预防疗法(PrEP)是一种高效的预防艾滋病毒感染的生物医学疗法。PrEP 的持续性对于实现预防 HIV 感染的最佳效果至关重要。然而,人们对美国 PrEP 的持续性知之甚少。本研究利用康涅狄格州所有付费者索赔数据库(APCD),在该州开具 PrEP 处方的患者中识别 PrEP 的持续性。作者根据康涅狄格州 APCD 确定了 1576 名开具 PrEP 处方的 PrEP 患者,并提取了医疗和药房报销单,对 2012-2018 年期间的纵向队列进行了评估。连续一个月(即 30 天)未领取药物的患者被定义为停止 PrEP。Kaplan-Meier 生存曲线和比例危险回归用于描述 PrEP 的持续性。在 1576 名领取 PrEP 处方的患者中,年龄中位数为 32.0(四分位数间距 [IQR]:22.0-44.0)。大多数患者为男性(93%)。在 1040 名中断 PrEP 的患者中,有 702 人(67.5%)至少重新开始过一次 PrEP。在首次使用 PrEP 的患者中,坚持 PrEP 的中位时间为 3 个月(IQR:1-6 个月)。在随后的 PrEP 使用中,坚持 PrEP 的时间中位数也在 3 个月左右。女性、使用父母的保险以及高额自费与较短的 PrEP 持续时间有关。在领取 PrEP 处方的患者中,PrEP 的持续时间较短。尽管许多患者重新开始了 PrEP,但在后续的 PrEP 使用过程中,坚持率仍然很低,这可能会导致 HIV 风险增加。需要采取有效的干预措施来提高 PrEP 的持续性并降低艾滋病毒的发病率。
{"title":"Long-Term HIV Pre-Exposure Prophylaxis Persistence and Reinitiation in Connecticut from 2012 to 2018.","authors":"Jun Tao, Mofan Gu, Omar Galarraga, Jhanavi Kapadia, Harrison Martin, Hannah Parent, Philip A Chan","doi":"10.1089/pop.2024.0012","DOIUrl":"10.1089/pop.2024.0012","url":null,"abstract":"<p><p>HIV pre-exposure prophylaxis (PrEP) is a highly effective biomedical prevention for HIV infections. PrEP persistence is critical to achieving optimal protection against HIV infection. However, little is known about PrEP persistence in the United States. This study utilized the Connecticut All-Payer Claims Database (APCD) to identify PrEP persistence among patients who filled their PrEP prescriptions in the state. The authors identified 1,576 PrEP patients who picked up PrEP prescriptions and extracted medical and pharmacy claims to evaluate a longitudinal cohort during 2012-2018 based on the Connecticut APCD. Patients who did not pick up medication for one consecutive month (ie, 30 days) were defined as discontinuing PrEP. Kaplan-Meier Survival Curve and proportional hazard regression were used to describe PrEP persistence. Of the 1,576 patients who picked up PrEP prescriptions, the median age was 32.0 (interquartile range [IQR]: 22.0-44.0). The majority were male individuals (93%). Of 1,040 patients who discontinued PrEP, 702 (67.5%) restarted PrEP at least once. The median time of PrEP persistence was 3 months (IQR: 1-6 months) for initial PrEP use. The median time on PrEP was also around 3 months in the following episodes of PrEP use. Being female, being on parent's insurance, and having high co-pays were associated with shorter periods of PrEP persistence. PrEP persistence was low among patients who picked up PrEP prescriptions. Although many patients restarted PrEP, persistence remained low during follow-up PrEP use and possibly led to periods of increased HIV risk. Effective interventions are needed to improve PrEP persistence and reduce HIV incidence.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"267-274"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among Specialists. 专科医生对带状疱疹疫苗接种的认识、态度和做法。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-01 Epub Date: 2024-06-05 DOI: 10.1089/pop.2023.0284
David Singer, Carolyn Sweeney, Nikita Stempniewicz, Maria Reynolds, Diana Garbinsky, Sara Poston

Recombinant zoster vaccine has been recommended by the US Advisory Committee on Immunization Practices (ACIP) for the prevention of herpes zoster (HZ) in immunocompetent adults aged at least 50 years since 2018. In January 2022, this was extended to immunodeficient/immunosuppressed adults aged at least 19 years. Key study objectives were to assess specialists' knowledge of the ACIP HZ vaccination recommendations, their attitudes toward HZ vaccination, and HZ vaccination practices/barriers. This cross-sectional, web-based survey (conducted in March 2022) included US dermatologists, gastroenterologists, infectious disease specialists, oncologists, and rheumatologists who treat patients with psoriasis, inflammatory bowel disease, human immunodeficiency syndrome, solid tumors/hematological malignancies, and rheumatoid arthritis, respectively. Although most of the 613 specialists correctly identified the ACIP HZ vaccination recommendations for adults aged at least 50 years (84%) and immunodeficient/immunosuppressed adults aged at least 19 years (67%), only 29% knew that recombinant zoster vaccine is recommended for individuals who have previously received zoster vaccine live, and only 18% knew all current ACIP recommendations. For patients with the diseases listed, 84% of specialists thought that HZ is a serious risk, 75% that HZ vaccination is extremely/very important, and 69% were extremely/very likely to recommend HZ vaccination. Only 36% administer vaccines themselves, mainly because patients receive vaccinations from others. Barriers to vaccination included more urgent/acute issues, insufficient time, and lack of patient motivation/willingness. Full knowledge of the ACIP HZ vaccination recommendations among the surveyed specialists was low. There may be a need to educate specialists to improve adherence to these recommendations. [Figure: see text].

自2018年起,美国免疫实践咨询委员会(ACIP)推荐将重组带状疱疹疫苗用于年龄至少50岁的免疫功能健全的成年人预防带状疱疹(HZ)。2022 年 1 月,这一范围扩大到年龄至少 19 岁的免疫缺陷/免疫抑制成人。研究的主要目的是评估专科医生对 ACIP HZ 疫苗接种建议的了解程度、他们对 HZ 疫苗接种的态度以及 HZ 疫苗接种实践/障碍。这项横断面网络调查(于 2022 年 3 月进行)的对象包括美国皮肤科医生、消化科医生、传染病专家、肿瘤专家和风湿病专家,他们分别负责治疗银屑病、炎症性肠病、人类免疫缺陷综合征、实体瘤/血液恶性肿瘤和类风湿性关节炎患者。虽然 613 名专科医生中的大多数都能正确识别 ACIP 针对 50 岁以上成人(84%)和 19 岁以上免疫缺陷/免疫抑制成人(67%)的带状疱疹疫苗接种建议,但只有 29% 的人知道重组带状疱疹疫苗推荐用于之前接种过带状疱疹活疫苗的人,只有 18% 的人知道 ACIP 目前的所有建议。对于所列疾病的患者,84% 的专科医生认为 HZ 风险严重,75% 认为接种 HZ 疫苗极其/非常重要,69% 极其/非常可能推荐接种 HZ 疫苗。只有 36% 的人自己接种疫苗,主要原因是病人从其他人那里接种疫苗。接种疫苗的障碍包括更紧急/急性的问题、时间不足以及患者缺乏动力/意愿。接受调查的专科医生对 ACIP HZ 疫苗接种建议的充分了解程度很低。可能需要对专科医生进行教育,以提高对这些建议的依从性。[图:见正文]。
{"title":"Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among Specialists.","authors":"David Singer, Carolyn Sweeney, Nikita Stempniewicz, Maria Reynolds, Diana Garbinsky, Sara Poston","doi":"10.1089/pop.2023.0284","DOIUrl":"10.1089/pop.2023.0284","url":null,"abstract":"<p><p>Recombinant zoster vaccine has been recommended by the US Advisory Committee on Immunization Practices (ACIP) for the prevention of herpes zoster (HZ) in immunocompetent adults aged at least 50 years since 2018. In January 2022, this was extended to immunodeficient/immunosuppressed adults aged at least 19 years. Key study objectives were to assess specialists' knowledge of the ACIP HZ vaccination recommendations, their attitudes toward HZ vaccination, and HZ vaccination practices/barriers. This cross-sectional, web-based survey (conducted in March 2022) included US dermatologists, gastroenterologists, infectious disease specialists, oncologists, and rheumatologists who treat patients with psoriasis, inflammatory bowel disease, human immunodeficiency syndrome, solid tumors/hematological malignancies, and rheumatoid arthritis, respectively. Although most of the 613 specialists correctly identified the ACIP HZ vaccination recommendations for adults aged at least 50 years (84%) and immunodeficient/immunosuppressed adults aged at least 19 years (67%), only 29% knew that recombinant zoster vaccine is recommended for individuals who have previously received zoster vaccine live, and only 18% knew all current ACIP recommendations. For patients with the diseases listed, 84% of specialists thought that HZ is a serious risk, 75% that HZ vaccination is extremely/very important, and 69% were extremely/very likely to recommend HZ vaccination. Only 36% administer vaccines themselves, mainly because patients receive vaccinations from others. Barriers to vaccination included more urgent/acute issues, insufficient time, and lack of patient motivation/willingness. Full knowledge of the ACIP HZ vaccination recommendations among the surveyed specialists was low. There may be a need to educate specialists to improve adherence to these recommendations. [Figure: see text].</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"231-240"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operation Allies Welcome Medical Response Unit at Philadelphia International Airport: A Framework for Medical Triage of High Volume of Displaced Persons Arriving by Air. 盟军行动欢迎费城国际机场的医疗响应单位:为大量乘飞机抵达的流离失所者进行医疗分流的框架。
IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-01 Epub Date: 2024-07-12 DOI: 10.1089/pop.2024.0003
Efrat R Kean, Maura Sammon, Cheryl Bettigole, Sage Myers, Setareh Mohammadie, Naomi Rosenberg, Patricia Henwood

In the aftermath of the US withdrawal from Afghanistan, over 100,000 individuals were evacuated to the United States, primarily arriving through Philadelphia International Airport and Dulles International Airport under Operation Allies Welcome. In Philadelphia, evacuees were greeted at the airport by a medical triage unit (MTU) that was rapidly assembled to provide on-site medical care. The MTU triaged emergent medical complaints, handled minor complaints on-site to reduce impact on local health care systems, distributed patients who did require a higher level of care among area hospitals, and ensured appropriate follow-up care for individuals with ongoing needs. Although there are regional and federal entities whose purview is the establishment and coordination of such responses, these entities were not mobilized to respond immediately when planes began to arrive carrying the first wave of evacuees as this event was not a designated disaster. The MTU was a grassroots effort initiated by local health care providers in coordination with the local Medical Reserve Corps and Department of Public Health. This article presents a framework for similar operations, anticipating an ongoing need for planning for sudden arrivals of large numbers of displaced persons, particularly via air travel, in a time of increasing mass displacement events, as well as a rationale for establishing more robust networks of local medical professionals willing to respond in the case of an emergency and involving them in the emergency planning processes to ensure preexisting protocols are practical.

美国从阿富汗撤军后,超过 100,000 人被疏散到美国,他们主要通过费城国际机场和杜勒斯国际机场的 "盟军欢迎行动 "抵达美国。在费城,迅速集结的医疗分流小组(MTU)在机场迎接撤离人员,提供现场医疗服务。医疗分流小组对紧急医疗投诉进行分流,现场处理轻微投诉以减少对当地医疗系统的影响,将确实需要更高一级护理的病人分流到地区医院,并确保为有持续需求的个人提供适当的后续护理。虽然有地区和联邦实体负责建立和协调此类应对措施,但由于此次事件不属于指定灾难,因此当飞机开始运送第一波疏散人员时,这些实体并未立即动员起来做出响应。医疗后备队是由当地医疗服务提供者与当地医疗后备队和公共卫生部协调发起的一项基层工作。本文提出了一个类似行动的框架,预计在大规模流离失所事件日益增多的情况下,需要不断为突然到来的大量流离失所者(尤其是通过航空旅行)制定计划,并提出了建立更强大的当地医疗专业人员网络的理由,这些专业人员愿意在紧急情况下做出反应,并让他们参与到应急计划过程中,以确保预先存在的协议切实可行。
{"title":"Operation Allies Welcome Medical Response Unit at Philadelphia International Airport: A Framework for Medical Triage of High Volume of Displaced Persons Arriving by Air.","authors":"Efrat R Kean, Maura Sammon, Cheryl Bettigole, Sage Myers, Setareh Mohammadie, Naomi Rosenberg, Patricia Henwood","doi":"10.1089/pop.2024.0003","DOIUrl":"10.1089/pop.2024.0003","url":null,"abstract":"<p><p>In the aftermath of the US withdrawal from Afghanistan, over 100,000 individuals were evacuated to the United States, primarily arriving through Philadelphia International Airport and Dulles International Airport under Operation Allies Welcome. In Philadelphia, evacuees were greeted at the airport by a medical triage unit (MTU) that was rapidly assembled to provide on-site medical care. The MTU triaged emergent medical complaints, handled minor complaints on-site to reduce impact on local health care systems, distributed patients who did require a higher level of care among area hospitals, and ensured appropriate follow-up care for individuals with ongoing needs. Although there are regional and federal entities whose purview is the establishment and coordination of such responses, these entities were not mobilized to respond immediately when planes began to arrive carrying the first wave of evacuees as this event was not a designated disaster. The MTU was a grassroots effort initiated by local health care providers in coordination with the local Medical Reserve Corps and Department of Public Health. This article presents a framework for similar operations, anticipating an ongoing need for planning for sudden arrivals of large numbers of displaced persons, particularly via air travel, in a time of increasing mass displacement events, as well as a rationale for establishing more robust networks of local medical professionals willing to respond in the case of an emergency and involving them in the emergency planning processes to ensure preexisting protocols are practical.</p>","PeriodicalId":20396,"journal":{"name":"Population Health Management","volume":" ","pages":"257-266"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Population Health Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1